Looking back: can a drug combo help more lung cancer patients before surgery?
NCT ID NCT07169708
Summary
This study looks back at the medical records of 100 patients in Taiwan with operable non-small cell lung cancer. It aims to see how well and how safely the drug nivolumab works when given with standard chemotherapy before surgery. The goal is to understand if this combination helps eliminate more cancer and allows patients to live longer without the disease coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.